Surv.m-CRA-2-1C

N/A

Report date: 2025/12/11 13:42:21

Base Information

Drug NameSurv.m-CRA-2-1C
Drug Alias NameSurv.m-CRA-2-1C
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSurv BioPharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesSurv BioPharma Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A